Tel Aviv, Israel

Anat Oren

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Ramat-Aviv, IL (2010)
  • Tel Aviv, IL (2010 - 2013)

Company Filing History:


Years Active: 2010-2013

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Anat Oren: Innovator in Pharmaceutical Peptides

Introduction

Anat Oren is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of pharmaceutical peptides, holding a total of 4 patents. His work focuses on developing innovative treatments for various medical conditions through the use of derived peptides.

Latest Patents

Anat Oren's latest patents include groundbreaking advancements in peptide technology. One of his notable inventions is related to Clusterin-derived peptides. This patent encompasses pharmaceutical compositions that include these peptides, methods for manufacturing them, and approaches for treating conditions through their administration. Additionally, it provides nucleotide sequences encoding these peptides, antibodies directed to their epitopes, and fusion proteins that incorporate them. Another significant patent involves GP96-derived peptides, which also includes pharmaceutical compositions and methods for treating a wide range of disorders and diseases. This patent further details nucleotide sequences, antibodies, and fusion proteins related to these peptides.

Career Highlights

Anat Oren is associated with Compugen Ltd., a corporation known for its innovative approaches in biotechnology. His work at Compugen has allowed him to explore the therapeutic potential of peptides, contributing to advancements in medical treatments.

Collaborations

Anat collaborates with talented individuals such as Zurit Levine and Zohar Tiran, enhancing the innovative environment at Compugen. Their combined expertise fosters a dynamic approach to research and development in the field of pharmaceuticals.

Conclusion

Anat Oren's contributions to the field of pharmaceutical peptides exemplify the impact of innovation in medicine. His patents reflect a commitment to advancing therapeutic options for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…